Shijiazhuang Shimu Pharmaceutical Co., Ltd., located in Shijiazhuang, China, is a leading manufacturer of veterinary pharmaceuticals and feed additives. Operating under the brand SMAPC, the company delivers a broad spectrum of veterinary solutions trusted by clients across more than 40 countries worldwide.
Core Business and Product Offerings
Shimu Pharmaceutical specializes in the development, production, and global distribution of veterinary medicinal products. Their extensive product portfolio includes:
-
Injectables:
- Ivermectin Injection
- Oxytetracycline Injection
- Tylosin Tartrate Injection
- Dexamethasone Sodium Phosphate Injection
- Enrofloxacin Injection
-
Oral Solutions:
- Multivitamin Oral Solution
- Florfenicol Oral Solution
- Vitamin AD3E Oral Solution
-
Powders:
- Kanamycin Sulfate Powder
- Avermectin Powder
- Albendazole Ivermectin Powder
- Doxycycline Hydrochloride Water Soluble Powder
-
Tablets/Bolus:
- Albendazole Tablets
- Ivermectin Tablets
- Praziquantel Tablets
-
Feed Additives:
- Olaquindox Premix
- Diclazuril Premix
-
Disinfectants:
- Povidone Iodine Solution
- Glutaral Solution
These products are manufactured in accordance with GMP standards, ensuring efficacy, safety, and compliance with global veterinary norms.
Unique Selling Proposition and Specialization
Shimu’s key differentiators include:
- A vertically integrated manufacturing model with strict quality control
- Complete product lines covering anti-parasitics, antibiotics, vitamins, minerals, and disinfectants
- Capability to produce customized formulations and private-label veterinary medicines
- Long-standing reputation for consistent product quality and regulatory compliance
The company serves a wide range of animal species including poultry, ruminants, swine, and aquaculture.
Financial Performance
Based on available market intelligence and trade data:
- Estimated Annual Revenue (2023): USD 25–30 million
- Export Share: Over 70% of sales revenue
- Top Export Markets: Middle East, Southeast Asia, Africa, Latin America
The company has demonstrated a steady growth trajectory with exports increasing at a rate of 15% annually.
Shipment and Export Data
Shimu Pharmaceutical is a dominant exporter of veterinary pharmaceuticals from China:
- Annual Export Volume: Over 800 metric tons of veterinary drugs and additives
- Countries Served: 40+ countries including Egypt, Nigeria, Vietnam, Philippines, and Peru
- Certifications Held: GMP, ISO 9001, and product-specific registrations in importing countries
They maintain a reliable logistics network for timely and temperature-controlled deliveries.
Market and Customer Base
Shimu’s clientele includes:
- Veterinary distributors and importers
- Animal health pharmaceutical resellers
- Poultry and livestock producers
- Governmental and NGO-led veterinary programs
The company partners with local agents in international markets to navigate regulatory approvals and provide technical support.
Capabilities and Infrastructure
- Manufacturing Area: Over 25,000 square meters of GMP-certified facilities
- Production Lines: Dedicated lines for injectables, powders, tablets, oral liquids, and premixes
- Technical Team: Composed of 50+ pharmacists, veterinarians, and quality assurance professionals
- R&D: In-house lab developing new generics and combination therapies tailored for emerging markets
The company operates a complete quality assurance and quality control (QA/QC) protocol including microbiological and chemical labs.
Certifications and Compliance
Shimu Pharmaceutical is committed to maintaining the highest standards in manufacturing and quality:
- GMP Certification (China Ministry of Agriculture)
- ISO 9001:2015 Quality Management System
- Product Registrations in over 30 countries
- In compliance with OIE and WHO guidance for veterinary pharmaceuticals
These credentials ensure confidence and compliance across global markets.
Customer Testimonials
"Shimu’s injectables have proven reliable and cost-effective for our poultry operations. Their Oxytetracycline is a mainstay product for us."
– Veterinary Distributor, Vietnam
"The consistency in Shimu’s product supply and their willingness to provide detailed COAs and support documentation has made them a key partner."
– Animal Health Importer, Egypt
Achievements
- Supplied over 1 billion doses of veterinary medications in 2023
- Opened a new export-focused R&D and regulatory office in 2022
- Participated in CPhI and VIV Asia trade exhibitions showcasing veterinary innovations
- Developed a water-soluble multivitamin complex specifically for heat-stressed poultry in tropical markets
Shijiazhuang Shimu Pharmaceutical Co., Ltd. continues to drive global animal health with an expanding footprint, comprehensive product offerings, and a firm commitment to quality and innovation.
